English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In order to make a broad vaccine for influenza-A virus, a conserve epitope must be considered. M2 is a conserve transmembran protein in all strain of influenza-A virus. Therefore, in this experiment we used 69 bp synthetic nucleotides from extracellular domain of M2 from H5N1 as an epitope (M2e) for influenza-A vaccine. A vaccine may usually more expose to immune system if they are made on a virus-like particles (VLPs). It was shown in many papers that the HBsAg-S protein is able to make a self assemble VLP. Therefore the synthetic M2e DNA was fused to a HBsAg-S gene, which encodes a small envelope protein of the Hepatitis B virus (HBsAg-S protein), which in turn creating a new VLP with M2e on it. This fusion replaced IPQ epitope of the HBsAg-S with M2e from M2 protein of the H5N1 virus. The fusion of M2e and HBsAg-S was conducted using asymmetric PCR. The single stranded DNA of M2e was produced with primers containing HBsAg-S gene sequence. Next, this single-stranded M2e was applied as mega primer for ‘fusion PCR’, which will fuse the M2e and part of the HBsAg-S fragment. A ~680 bp DNA band (fusion of M2e and HBsAg-S fragment) is generated from the ‘fusion PCR’. Alignment between hypothetic fusion sequence and the result was compared with native HBsAg-S sequence. The analysis shows that the IPQ epitope from HBsAg-S was totally replaced by the M2e.. KeyWord: A-H5N1 VLPs vaccine, asymmetric PCR, HBsAg-S, M2.

Fusion Strategy of Influenza A-H5N1 Virus M2e Epitope DNA Sequence to Hepatitis B Virus HBsAg-S Gene